Warren L DeLano

Title: Warren L. DeLano: A Pioneer in Bioactive Compound Innovation

Introduction

Warren L. DeLano, an accomplished inventor based in San Carlos, CA, has made significant contributions to the field of bioactive compounds through his innovative research and development efforts. With a portfolio of three patents, DeLano is recognized for his advancements in methods and compositions that prolong the elimination half-times of bioactive compounds, showcasing his expertise and commitment to enhancing therapeutic and diagnostic agents.

Latest Patents

DeLano's latest patents focus on peptide ligands that display affinity for immunoglobulin G (IgG) or serum albumin. These patents describe hybrid molecules that consist of a peptide ligand domain and an active domain, which may include various therapeutic or diagnostic agents. The innovative hybrid molecules are designed to alter the elimination half-times of active domain molecules. By leveraging binding affinities, these molecules can incorporate bioactive compounds with short elimination half-times, thereby prolonging their effectiveness within biological systems. The hybrid molecules can be produced through various techniques, including recombinant organism production or chemical synthesis.

Career Highlights

Throughout his career, Warren L. DeLano has worked with reputable organizations, including Genentech, Inc. and Sunesis Pharmaceuticals, Inc. His roles at these companies allowed him to collaborate with leading scientists and contribute to pioneering projects that push the boundaries of biotechnological innovation. His expertise in bioactive compounds has cemented his reputation as a significant figure in the field.

Collaborations

During his journey, DeLano has collaborated with notable peers, including Mark S. Dennis and Henry Bernard Lowman. These collaborations have not only enriched his research efforts but also facilitated the exchange of groundbreaking ideas that continue to influence advancements in medical and therapeutic technologies.

Conclusion

Warren L. DeLano stands out as a visionary inventor dedicated to improving the efficacy of bioactive compounds through innovative hybrid technologies. His work exemplifies the intersection of scientific inquiry and practical application, continually driving the field of biotechnology forward. As he continues to develop new methodologies and compositions, DeLano's contributions will undoubtedly have lasting impacts in therapeutic and diagnostic spheres.